ASHG 2019 logo
Results based on the FinnGen data are presented in several talks and posters during the 69th Annual Meeting of the American Society of Human Genetics (ASHG) in Houston, October 15-19. Come and meet our researchers!
Autumn in Helsinki
The next FinnGen Face-to-Face meeting will be organized 11 - 12 September in Helsinki. 
Fingenious
Undertaking biobank research is getting easier and faster. Through FINGENIOUS (TM) you can now reach all six Finnish hospital biobanks by completing just one feasibility and access request. FINGENIOUS (TM) helps both academics and businesses to investigate the availability of biobank samples and related data.
New FinnGen animation released!
With this new animation we hope to be able to explain all the essential characteristics of the FinnGen study in a way that is both entertaining and enlightening.
GSK and Sanofi join FinnGen
HELSINKI, Finland, January 22, 2019

GSK and Sanofi have joined the FinnGen study, a large public private partnership aiming to collect and analyse genome and health data from 500 000 Finns and thereby generate novel medically and therapeutically relevant insights.
Want to work with us?
We are looking for bioinformaticians with experience on large scale genetic analyses (e.g. GWAS, exome sequencing). The data-analyst would be working in one of the largest genetic projects in the world, FinnGen.
Want to work with us?
We are looking for a bioinformatician to look after our data repository of human genome data as a part of the data team. The work includes managing various data collections, performing data retrieval and pre-processing for research projects, and developing tools and practices for data management and processing.
Aarno Palotie
Several FinnGen researchers are participating in the ASHG 2018 meeting.
Cambridge FinnGen F2F 2018 meeting participants
The next FinnGen Face-to-Face meeting will be organized 24 - 25 October 2018 in Helsinki. 
Biobank sample tubes
A unique study that combines genome information with digital health care data has been launched in Finland. The FinnGen study plans to analyse up to 500 000 unique blood samples collected by a nation-wide network of Finnish biobanks. The goal is to deepen our understanding about the origins of diseases and their treatment. The project is expected to continue for six years, with a current budget of €59M.